Cite

HARVARD Citation

    Ellsworth, P. et al. (n.d.). Solabegron: a potential future addition to the β-3 adrenoceptor agonist armamentarium for the management of overactive bladder. Expert opinion on investigational drugs. pp. 413-419. [Online]. 
  
Back to record